- Home
- FTCI vs KPTI Comparison
FTCI vs KPTI Comparison
Compare FTCI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTCI | KPTI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 36.7M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FTCI | KPTI |
|---|---|---|
| Price | $1.63 | $0.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $10.20 | $7.25 |
| AVG Volume (30 Days) | 469.8K | ★ 1.2M |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $99,687,000.00 | ★ $146,067,000.00 |
| Revenue This Year | $38.06 | N/A |
| Revenue Next Year | $58.28 | $27.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 110.51 | 0.57 |
| 52 Week Low | $1.62 | $0.31 |
| 52 Week High | $12.75 | $10.99 |
Technical Indicators
Market Signals| Indicator | FTCI | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 28.40 | 18.15 |
| Support Level | N/A | N/A |
| Resistance Level | $2.86 | $2.16 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 1.39 | 5.95 |
Price Performance
Historical ComparisonAbout FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S.-manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).